Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Steroid-Refractory Chronic GVHD
NCT00472225Phase 2Unknown
- Sponsor
- Korean Society of Blood and Marrow Transplantation
- Start
- May 2007
- Primary completion
- May 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in chronic graft-versus-host disease (cGVHD), sponsored by Korean Society of Blood and Marrow Transplantation. Status: unknown.
02
Drugs
rituximab
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT00472225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472225.